particular concern is preparing the NGOs that programs to combat HIV / AIDS in developing countries is not the necessary financial commitments are obtained. Not more wordy explanations about the severity of the problem are in demand, but concrete grants to do something about it can. 10 million people are increasingly realizing women have to rely on treatment by 2010, and 7 million were already there, raises Oxfam Interantional out. "Germany has the issue on the agenda, and wants a success. The opportunity must not be missed. Some countries, including Italy and Canada are trying, apparently to prevent any commitment to specific numbers. The negotiations are in full swing. The German negotiators should persevere until the checks are signed, "said Reinhard Hermle, development policy adviser at Oxfam Germany.
Oxfam occurs also advocate that the G8 to contribute to overcoming the glaring lack of skilled health care personnel in the order of 4.25 million missing doctors, doctors and nurses and to strengthen public health systems in developing countries. The financing must be holistic and coordinated. Hospitals without medical researchers and nurses do not help.
After Oxfam's opinion is also hampered access to affordable medicines through existing trade rules to allow the drug companies monopoly rights to the competition threaten with generics and keep drug prices high. The drugs campaign MSF pointed out that the so-called outreach agenda constitutes a direct threat to access to affordable medicines in Latin America. O5 is the account under which the federal government to "take responsibility", the emerging economies of Brazil, China, India, Mexico and South Africa. Countries such as Brazil and India but the most important producers of generic drugs for their own population and the development of the world at large. The lever that could prevent in the future is the "strengthening of intellectual property rights."
0 comments:
Post a Comment